{"cik":1280776,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"Immunic, Inc.","units":{"EUR":[{"end":"2019-04-12","val":5300000,"accn":"0001280776-19-000051","fy":2019,"fp":"Q2","form":"10-Q","filed":"2019-08-08","frame":"CY2019Q1I"}],"USD":[{"start":"2018-01-01","end":"2018-09-30","val":-357000,"accn":"0001280776-18-000104","fy":2018,"fp":"Q3","form":"10-Q","filed":"2018-11-08"},{"start":"2018-07-01","end":"2018-09-30","val":-119000,"accn":"0001280776-18-000104","fy":2018,"fp":"Q3","form":"10-Q","filed":"2018-11-08","frame":"CY2018Q3"},{"start":"2018-01-01","end":"2018-12-31","val":357000,"accn":"0001280776-19-000025","fy":2018,"fp":"FY","form":"10-K","filed":"2019-03-04","frame":"CY2018"},{"end":"2019-04-12","val":6000000,"accn":"0001280776-19-000051","fy":2019,"fp":"Q2","form":"10-Q","filed":"2019-08-08","frame":"CY2019Q1I"},{"start":"2020-01-01","end":"2020-06-30","val":1500000,"accn":"0001280776-20-000024","fy":2020,"fp":"Q2","form":"10-Q","filed":"2020-08-03"},{"start":"2020-01-01","end":"2020-06-30","val":1500000,"accn":"0001280776-20-000028","fy":2020,"fp":"Q2","form":"10-Q/A","filed":"2020-08-03"},{"end":"2026-03-27","val":1100000,"accn":"0001280776-26-000010","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-13","frame":"CY2026Q1I"},{"start":"2026-01-01","end":"2026-03-31","val":1900000,"accn":"0001280776-26-000010","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-13","frame":"CY2026Q1"}]}}